Wednesday, February 27, 2013

Novartis has fair claim to challenge German drug pricing law though weak case to protect diabetes drugs - FT.com

Novartis has fair claim to challenge German drug pricing law though weak case to protect diabetes drugs - FT.com

No comments:

Post a Comment